Isthmus Partners LLC Invests $115,000 in HCA Healthcare, Inc. (NYSE:HCA)

Isthmus Partners LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 35,938 shares of the company’s stock, valued at approximately $115,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Atlantic Edge Private Wealth Management LLC bought a new stake in HCA Healthcare during the 4th quarter valued at approximately $27,000. Bangor Savings Bank raised its position in shares of HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares during the last quarter. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at approximately $27,000. Unique Wealth Strategies LLC bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $28,000. Finally, GPS Wealth Strategies Group LLC lifted its position in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Oppenheimer increased their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. JPMorgan Chase & Co. boosted their price target on HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a research note on Thursday, May 30th. Truist Financial boosted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. UBS Group increased their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Finally, Morgan Stanley initiated coverage on shares of HCA Healthcare in a research note on Tuesday. They issued an “equal weight” rating and a $427.00 target price for the company. Five analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $359.89.

HCA Healthcare Trading Down 2.5 %

NYSE HCA traded down $9.77 during trading hours on Friday, hitting $387.98. The company’s stock had a trading volume of 2,248,803 shares, compared to its average volume of 1,129,325. The stock has a fifty day moving average of $355.43 and a 200 day moving average of $335.92. The firm has a market capitalization of $101.62 billion, a P/E ratio of 19.34, a PEG ratio of 1.52 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $403.05. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.29 earnings per share. Equities research analysts forecast that HCA Healthcare, Inc. will post 22.5 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Insiders Place Their Bets

In related news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the transaction, the senior vice president now owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 8,844 shares of company stock worth $3,185,932. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.